- Dabigatran, sold
under the
brand name
Pradaxa among others, is an
anticoagulant used to
treat and
prevent blood clots and to
prevent stroke in people...
- (pramipexole) Ofev /
Vargatef (Nintedanib)
Mobic /
Movalis (meloxicam)
Pradaxa (dabigatran etexilate)
Spiriva (tiotropium bromide)
Trajenta / Tradjenta...
- PMID 32420006. "Human
medicines European public ****essment
report (EPAR):
Pradaxa,
dabigatran etexilate, Arthroplasty, Replacement,Venous Thromboembolism...
-
Zostavax 202,240 15.17% Eisai,
Merck & Co.
Herpes zoster Aug-1999 May-2013 88
Pradaxa Dabigatran 200,697 -0.53%
Boehringer Ingelheim,
Lilly Icos Oral anticoagulant...
- DOACs—including
rivaroxaban (Xarelto),
apixaban (Eliquis), and
dabigatran (
Pradaxa)—came to the market. The New York
Times described a "furious battle" among...
- "FDA
approves Praxbind, the
first reversal agent for the
anticoagulant Pradaxa". U.S. Food and Drug
Administration (FDA) (Press release).
Archived from...
- failure.
Dabigatran is an oral
direct thrombin inhibitor.
Dabigatran (
Pradaxa) was
found to be
noninferior to
Warfarin in
prevention of
ischemic stroke...
-
DOACs in
pregnant women. Currently,
rivaroxaban (Xarelto),
dabigatran (
Pradaxa), and
edoxaban (Savaysa) are
DOACs listed under Pregnancy Category C, and...
- hemorrhage. The U.S. Food and Drug
Administration (FDA)
approved Dabigatran ("
Pradaxa," and
other names) on 19
October 2010, for
prevention of
stroke in patients...
- Food and Drug Administration.
Retrieved 18
September 2012. "FDA
approves Pradaxa to
prevent stroke in
people with
atrial fibrillation". Food and Drug Administration...
